Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-060671
Filing Date
2022-12-12
Accepted
2022-12-12 16:02:51
Documents
1
Period of Report
2022-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3583
  Complete submission text file 0001209191-22-060671.txt   5099
Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Issuer) CIK: 0001822711 (see all company filings)

EIN.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PARDES BIOSCIENCES, INC. 2173 SALK AVE., SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address
Brusky Sean P. (Reporting) CIK: 0001884733 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40067 | Film No.: 221457143